Sector & Industry Research
Biological Products, (No Diagnostic Substances) Stocks
Explore companies assigned to Biological Products, (No Diagnostic Substances). Open a stock page for detailed price, fundamentals, technical indicators, forecasts and available filings.
COMPANY UNIVERSE
Biological Products, (No Diagnostic Substances) company directory
Sorted by available market capitalization. Missing values remain at the bottom; this is not an investment recommendation.
150stocks foundDatabase classification
Companies in Biological Products, (No Diagnostic Substances)
Click a ticker or company to open its stock research page.
| Ticker | Company | Industry | Exchange | Market cap | Research |
|---|---|---|---|---|---|
| AMGN | Amgen Inc | Biological Products, (No Diagnostic Substances) | XNAS | $221,647,360,000 | Open research → |
| GILD | Gilead Sciences Inc | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $187,444,020,781 | Open research → |
| MRNA | Moderna, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $89,828,075,025 | Open research → |
| RVMD | Revolution Medicines, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $40,672,478,680 | Open research → |
| BIIB | Biogen Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $32,273,905,783 | Open research → |
| EXEL | Exelixis Inc | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $14,832,212,083 | Open research → |
| NBIX | Neurocrine Biosciences Inc | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $14,478,909,342 | Open research → |
| HALO | Halozyme Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $12,532,449,160 | Open research → |
| TECH | Bio-Techne Corp. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $11,363,049,525 | Open research → |
| PCVX | Vaxcyte, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $11,150,824,994 | Open research → |
| IBRX | ImmunityBio, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $11,138,879,229 | Open research → |
| RGEN | Repligen Corp | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $11,039,704,666 | Open research → |
| TWST | Twist Bioscience Corporation | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $10,593,601,582 | Open research → |
| KRYS | Krystal Biotech, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $9,815,270,006 | Open research → |
| QGEN | QIAGEN N.V. | Biological Products, (No Diagnostic Substances) | XNYS | $9,370,743,100 | Open research → |
| KYMR | Kymera Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $9,346,129,463 | Open research → |
| IOVA | Iovance Biotherapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $6,622,442,336 | Open research → |
| IMVT | Immunovant, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $6,293,660,221 | Open research → |
| KOD | Kodiak Sciences Inc | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $6,276,775,271 | Open research → |
| CGON | CG Oncology, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $5,607,390,123 | Open research → |
| SRRK | Scholar Rock Holding Corporation | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $5,138,121,048 | Open research → |
| CRSP | CRISPR Therapeutics AG | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $4,877,177,417 | Open research → |
| ADPT | Adaptive Biotechnologies Corporation | Biological Products, (No Diagnostic Substances) | XNAS | $4,170,623,655 | Open research → |
| RLAY | Relay Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $3,918,252,362 | Open research → |
| TARS | Tarsus Pharmaceuticals, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $3,423,279,894 | Open research → |
| DNLI | Denali Therapeutics Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $2,984,351,014 | Open research → |
| BEAM | Beam Therapeutics Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $2,540,876,559 | Open research → |
| ADMA | ADMA Biologics, Inc. | Biological Products, (No Diagnostic Substances) | XNAS | $2,430,033,074 | Open research → |
| RXRX | Recursion Pharmaceuticals, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $2,338,141,939 | Open research → |
| BCRX | BioCryst Pharmaceuticals Inc | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $2,118,386,020 | Open research → |
| NVAX | Novavax Inc | Biological Products, (No Diagnostic Substances) | XNAS | $2,098,318,500 | Open research → |
| VCEL | Vericel Corporation | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $2,053,385,221 | Open research → |
| VIR | Vir Biotechnology, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $1,979,826,709 | Open research → |
| TSHA | Taysha Gene Therapies, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $1,462,992,617 | Open research → |
| MAZE | Maze Therapeutics, Inc. | Biological Products, (No Diagnostic Substances) | XNAS | $1,461,153,526 | Open research → |
| COAG | Hemab Therapeutics Holdings, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $1,442,937,294 | Open research → |
| INBX | Inhibrx Biosciences, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $1,398,324,877 | Open research → |
| REPL | Replimune Group, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $1,264,427,488 | Open research → |
| VOR | Vor Biopharma Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $1,177,329,651 | Open research → |
| IMTX | Immatics N.V. | Biological Products, (No Diagnostic Substances) | XNAS | $1,131,032,322 | Open research → |
| CGEM | Cullinan Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $994,923,569 | Open research → |
| ODTX | Odyssey Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $913,112,013 | Open research → |
| GLUE | Monte Rosa Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $878,728,030 | Open research → |
| MGTX | MeiraGTx Holdings plc | Biological Products, (No Diagnostic Substances) | XNAS | $869,107,091 | Open research → |
| SLBT | SL Science Holding Limited | Biological Products, (No Diagnostic Substances) | XNAS | $846,747,233 | Open research → |
| SANA | Sana Biotechnology, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $835,216,177 | Open research → |
| DNA | Ginkgo Bioworks Holdings, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNYS | $763,638,741 | Open research → |
| ATTO | Attovia Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $744,572,083 | Open research → |
| CADL | Candel Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $739,169,338 | Open research → |
| SLDB | Solid Biosciences Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $736,637,385 | Open research → |
| FDMT | 4D Molecular Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $736,405,333 | Open research → |
| PRME | Prime Medicine, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $723,693,655 | Open research → |
| AURA | Aura Biosciences, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $674,599,783 | Open research → |
| ETRA | Electra Therapeutics, Inc. | Biological Products, (No Diagnostic Substances) | XNAS | $567,413,273 | Open research → |
| RGNX | REGENXBIO Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $532,726,459 | Open research → |
| ENTX | Entera Bio Ltd. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $462,399,161 | Open research → |
| TECX | Tectonic Therapeutic, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $456,086,709 | Open research → |
| EDIT | Editas Medicine, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $436,167,299 | Open research → |
| EIKN | Eikon Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $404,612,774 | Open research → |
| SCTX | Scribe Therapeutics Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $400,783,666 | Open research → |
| KYTX | Kyverna Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $395,179,607 | Open research → |
| ZURA | Zura Bio Limited | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $383,316,548 | Open research → |
| FENC | Fennec Pharmaceuticals Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $375,569,273 | Open research → |
| XFOR | X4 Pharmaceuticals, Inc. | Biological Products, (No Diagnostic Substances) | XNAS | $367,661,098 | Open research → |
| PROK | ProKidney Corp. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $363,532,877 | Open research → |
| CCCC | C4 Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $350,621,638 | Open research → |
| SRZN | Surrozen, Inc. Common | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $348,963,137 | Open research → |
| ALLO | Allogene Therapeutics, Inc. | Biological Products, (No Diagnostic Substances) | XNAS | $336,407,095 | Open research → |
| ARTV | Artiva Biotherapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $332,452,823 | Open research → |
| CABA | Cabaletta Bio, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $330,613,618 | Open research → |
| OCGN | Ocugen, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $324,019,988 | Open research → |
| AGEN | Agenus Inc. | Biological Products, (No Diagnostic Substances) | XNAS | $311,688,520 | Open research → |
| IKT | Inhibikase Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $274,885,723 | Open research → |
| SABS | SAB Biotherapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $271,139,377 | Open research → |
| PALI | Palisade Bio, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $268,376,659 | Open research → |
| IPSC | Century Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $266,180,722 | Open research → |
| LXEO | Lexeo Therapeutics, Inc. | Biological Products, (No Diagnostic Substances) | XNAS | $262,223,713 | Open research → |
| FATE | Fate Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $261,208,721 | Open research → |
| LCTX | Lineage Cell Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XASE | $251,390,019 | Open research → |
| STRO | Sutro Biopharma, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $236,613,310 | Open research → |
| ALEC | Alector, Inc. | Biological Products, (No Diagnostic Substances) | XNAS | $224,672,714 | Open research → |
| PLX | Protalix BioTherapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XASE | $223,989,165 | Open research → |
| IVVD | Invivyd, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $212,580,008 | Open research → |
| CGEN | Compugen Ltd | Biological Products, (No Diagnostic Substances) | XNAS | $200,823,203 | Open research → |
| LIMN | Liminatus Pharma, Inc. | Biological Products, (No Diagnostic Substances) | XNAS | $181,977,661 | Open research → |
| DTIL | Precision BioSciences, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $177,477,992 | Open research → |
| CMPX | Compass Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $177,098,456 | Open research → |
| CHRS | Coherus Oncology, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $165,316,034 | Open research → |
| TARA | Protara Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $162,808,069 | Open research → |
| CRDL | Cardiol Therapeutics Inc. | Biological Products, (No Diagnostic Substances) | XNAS | $157,966,829 | Open research → |
| VYGR | Voyager Therapeutics, Inc. | Biological Products, (No Diagnostic Substances) | XNAS | $148,342,264 | Open research → |
| OTLK | Outlook Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $145,800,740 | Open research → |
| ACOG | Alpha Cognition Inc. | Biological Products, (No Diagnostic Substances) | XNAS | $144,827,146 | Open research → |
| ARMP | Armata Pharmaceuticals, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XASE | $143,522,439 | Open research → |
| AVXL | Anavex Life Sciences | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $142,753,137 | Open research → |
| LONA | LeonaBio, Inc. | Biological Products, (No Diagnostic Substances) | XNAS | $136,425,713 | Open research → |
| TNYA | Tenaya Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $130,120,676 | Open research → |
| ENGN | enGene Therapeutics Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $115,938,227 | Open research → |
| LENZ | LENZ Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $114,527,150 | Open research → |
| HUMA | Humacyte, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $112,591,572 | Open research → |
| BDTX | Black Diamond Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $103,991,282 | Open research → |
| ATRA | Atara Biotherapeutics, Inc | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $92,648,063 | Open research → |
| NMRA | Neumora Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $89,382,085 | Open research → |
| CGTX | Cognition Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $85,127,921 | Open research → |
| CRDF | Cardiff Oncology, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $82,462,964 | Open research → |
| PTHS | Pelthos Therapeutics Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XASE | $78,483,615 | Open research → |
| OKYO | OKYO Pharma Limited | Biological Products, (No Diagnostic Substances) | XNAS | $74,520,928 | Open research → |
| CSBR | Champions Oncology, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $69,314,474 | Open research → |
| GRML | Greenland Mines Ltd. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $69,004,672 | Open research → |
| KLRS | Kalaris Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $56,179,755 | Open research → |
| ALGS | Aligos Therapeutics, Inc. | Biological Products, (No Diagnostic Substances) | XNAS | $55,387,590 | Open research → |
| INKT | MiNK Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $54,704,181 | Open research → |
| INMB | INmune Bio Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $52,454,661 | Open research → |
| CRBU | Caribou Biosciences, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $51,588,255 | Open research → |
| BKHA | Black Hawk Acquisition Corporation | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $51,213,604 | Open research → |
| BSEM | BioStem Technologies, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $49,294,410 | Open research → |
| EXOZ | eXoZymes Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $48,849,680 | Open research → |
| IMA | ImageneBio, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $48,130,173 | Open research → |
| ELOX | Eloxx Pharmaceuticals, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $47,214,954 | Open research → |
| TIL | Instil Bio, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $45,710,518 | Open research → |
| TVGN | Tevogen Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $44,148,241 | Open research → |
| MGX | Metagenomi Therapeutics, Inc. | Biological Products, (No Diagnostic Substances) | XNAS | $37,581,094 | Open research → |
| ELUT | Elutia Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $36,454,465 | Open research → |
| CVM | Cel-Sci Corporation | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XASE | $34,298,525 | Open research → |
| QNCX | Quince Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $32,271,409 | Open research → |
| ATYR | aTyr Pharma, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $25,041,720 | Open research → |
| SCLX | Scilex Holding Company | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $20,541,432 | Open research → |
| JSPR | Jasper Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $18,973,155 | Open research → |
| ESLA | Estrella Immunopharma, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $17,834,124 | Open research → |
| DYAI | Dyadic International, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $17,804,310 | Open research → |
| TCRX | TScan Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $16,131,463 | Open research → |
| BCDA | BioCardia, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $16,047,109 | Open research → |
| INAB | IN8bio, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $13,210,233 | Open research → |
| PLUR | Pluri Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $12,021,125 | Open research → |
| PASG | Passage Bio, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $11,873,719 | Open research → |
| INTS | Intensity Therapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $11,851,511 | Open research → |
| SNTI | Senti Biosciences Holdings, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $9,792,111 | Open research → |
| CELZ | Creative Medical Technology Holdings, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $6,532,636 | Open research → |
| PMCB | PharmaCyte Biotech, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $4,341,496 | Open research → |
| AIM | AIM ImmunoTech Inc. | Biological Products, (No Diagnostic Substances) | XASE | $3,074,518 | Open research → |
| CLDI | Calidi Biotherapeutics, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XASE | $2,687,551 | Open research → |
| HLSQ | Tessera Defense and Homeland Security Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XASE | $2,572,546 | Open research → |
| VIVS | VivoSim Labs, Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $2,411,681 | Open research → |
| CRIS | Curis Inc | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $1,720,350 | Open research → |
| SLXN | Silexion Therapeutics Corp | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | $1,193,231 | Open research → |
| ALVO | Alvotech | Biological Products, (No Diagnostic Substances) | XNAS | — | Open research → |
| ABOS | Acumen Pharmaceuticals, Inc. | Biological Products, (No Diagnostic Substances) | XNAS | — | Open research → |
| IAM | Iambic Therapeutics, Inc. | Biological Products, (No Diagnostic Substances) | XNAS | — | Open research → |
| TRXB | TRex Bio, Inc. | Biological Products, (No Diagnostic Substances) | XNAS | — | Open research → |
| IRLA | IRulya Therapeutics Inc. | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) | XNAS | — | Open research → |
Classification reflects stored metadata. Market cap may be stale or unavailable. Not financial advice.